Does the flavour of medicine affect the compliance?

Article Sidebar

PDF (Język Polski)


Published: Apr 12, 2017
Keywords:
compliance, cefuroxime axetil, oral pharmacotherapy

Main Article Content

Agnieszka Mastalerz-Migas
Katedra i Zakład Medycyny Rodzinnej, Uniwersytet Medyczny we Wrocławiu
Marek Postuła
1. Klinika Kardiologii i Nadciśnienia Tętniczego, Centralny Szpital Kliniczny Ministerstwa Spraw Wewnętrznych w Warszawie. 2. Centrum Badań Przedklinicznych i Technologii (CePT), Katedra i Zakład Farmakologii Doświadczalnej i Klinicznej, Warszawski Uniwersytet Medyczny
Agnieszka Sękowska
1. Poradnia Leczenia Bólu, Klinika Anestezjologii i Intensywnej Terapii, Centrum Medyczne Kształcenia Podyplomowego w Warszawie. 2. II Klinika Ginekologii i Położnictwa, Centrum Medyczne Kształcenia Podyplomowego w Warszawie

Abstract

Compliance is very important for an effective pharmacotherapy and also antibiotic therapy. The flavour is an important feature of medicine for today’s patients. The bitter flavour of the tablets (eg. cefuroxime axetil) may result in discontinuation of therapy, so it’s very important to choose the form of preparation of tablets, as patients don’t like a bitter taste. Incorporating a more palatable taste would increase the chance of compliance, and consequently, the effectiveness of antibiotic therapy, and also decrease the risk of recurrence, reinfection or drug resistance

Downloads

Download data is not yet available.

Article Details

How to Cite
Mastalerz-Migas , A., Postuła , M., & Sękowska , A. (2017). Does the flavour of medicine affect the compliance?. Alergoprofil, 13(2), 57-60. Retrieved from https://journalsmededu.pl/index.php/alergoprofil/article/view/888
Issue
Vol 13 No 2 (2017)
Section
Article

Copyright: © Medical Education sp. z o.o. This is an Open Access article distributed under the terms of the Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). License (https://creativecommons.org/licenses/by-nc/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.

Address reprint requests to: Medical Education, Marcin Kuźma (marcin.kuzma@mededu.pl)

References

1. Baguley D., Lim E., Bevan A. et al.: Prescribing for children – taste and palatability affect adherence to antibiotics: a review. Arch. Dis. Child. 2012, 97(3): 293-297.
2. Union E., Paot Cot E.: Regulation (EC) No 1901/2006 of the European Parliament and of the Council of the European Union of 12 December 2006 on medicinal products for paediatric use and amending Regulation (EEC) No 1768/92, Directive 2001/20/EC, Directive 2001/83/EC and Regulation (EC) No 726/2004: Chapter 3: Section 1: Article 15. Official Journal of the European Union 2006: 378-378.
3. Cohen R., de La Rocque F., Lécuyer A. et al.: Study of the acceptability of antibiotic syrups, suspensions, and oral solutions prescribed to pediatric outpatients. Eur. J. Pediatr. 2009, 168(7): 851-857.
4. Sunakawa K., Akita H., Iwata S. et al.: Rational use of oral antibiotics for pediatric infections. Infection 1995, 23(Suppl 2): S74-S78.
5. al-Shammari S.A., Khoja T., al-Yamani M.J.: Compliance with short-term antibiotic therapy among patients attending primary health centres in Riyadh, Saudi Arabia. J R Soc. Health 1995, 115: 231-234.
6. Dagan R., Shvartzman P., Liss Z.: Variation in acceptance of common oral antibiotic suspensions. Pediatr. Infect. Dis. J. 1994, 13: 686-690.